SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Johnson & Johnson (JNJ)

NEW YORK, Feb. 8, 2018

The investigation concerns whether J&J and certain of its officers and/or directors have violated Federal Securities Laws.

On February 5, 2018, CNBC reported that "court proceedings could expose potentially damaging documents" in connection with J&J's talc products, such as Johnson's Baby Powder. Following this news, J&J  stock dropped $7.29 per share or over 5% to close at $130.39 per share on February 5, 2018. Then, on February 7, 2018, the Beasley Allen Law Firm published a press release stating that "[l]awsuits filed by ovarian cancer and mesothelioma victims are revealing never-before-seen documents from Johnson & Johnson and talc supplier, Imerys, that shed light on just how prevalent asbestos and heavy metals are in the talc used in Baby Powder." The release continued that "[i]nternal Johnson & Johnson documents from 1972 note that asbestos was found in 100 percent of talc samples tested at the time, but this information was never released publicly," and continued to explain how J&J stopped testing talc samples for asbestos contamination after majority of the sample batches were found to be positive for asbestos. Following this news, J&J stock dropped. 

If you are aware of any facts relating to this investigation, or purchased J&J shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/jnj. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com